IL1B and irritable bowel syndrome: One hypothesis suggests that gut dysbiosis may contribute to enhanced cytokines release (e.g., IL-1β, IL-6, TNF-α), resulting in a higher activation of the HPA axis and enhancing the risk of developing symptoms of anxiety and depression in IBD [53, 55–57].